GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hofseth Biocare A HBC.OL · NOK

Health Care · Oslo Børs · 🇳🇴 Norway

Compare

1.14

+3.64%

Close of 9 Nov 2026, in NOK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in NOK, from our data supplier.

FY2025

Revenue

NOK 256.3m

FY2016FY2025

Net income

−NOK 134.9m

FY2016FY2025

Free cash flow

−NOK 48.3m

FY2016FY2025

Shareholders' equity

−NOK 74.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueNOK 256.3mNOK 257.4mNOK 194.9mNOK 120.4mNOK 87.6mNOK 69.3mNOK 67.8mNOK 60.7mNOK 118.5mNOK 20.2m
Research and developmentNOK 12.4mNOK 15.0mNOK 11.0mNOK 13.6mNOK 12.5mNOK 7.6mNOK 131,000NOK 2.4mNOK 1.3mNOK 1.8m
Operating income—−NOK 102.1m−NOK 99.1m−NOK 127.2m−NOK 117.1m−NOK 92.0m−NOK 80.6m−NOK 80.7m−NOK 13.3m−NOK 137.1m
Net income−NOK 134.9m−NOK 123.4m−NOK 106.7m−NOK 137.4m−NOK 126.5m−NOK 102.1m−NOK 89.2m−NOK 84.8m−NOK 16.5m−NOK 147.4m
Diluted earnings per share-0.32-0.30-0.27-0.35-0.35-0.31-0.29-0.33-0.07-1.09

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsNOK 394.3mNOK 341.4mNOK 390.1mNOK 411.0mNOK 416.0mNOK 459.1mNOK 293.0mNOK 187.9mNOK 184.2mNOK 159.4m
Cash and short-term investmentsNOK 63.3mNOK 25.6mNOK 23.9mNOK 29.9mNOK 47.2mNOK 170.7mNOK 93.2mNOK 48.6mNOK 40.7mNOK 15.2m
Total liabilitiesNOK 469.1mNOK 280.1mNOK 349.0mNOK 263.0mNOK 275.6mNOK 195.4mNOK 175.3mNOK 101.9mNOK 147.2mNOK 105.8m
DebtNOK 228.6mNOK 170.9mNOK 280.8mNOK 104.2mNOK 139.2mNOK 100.8mNOK 135.4mNOK 58.3mNOK 81.4mNOK 74.4m
Shareholders' equity−NOK 74.8mNOK 60.0mNOK 41.8mNOK 148.7mNOK 141.1mNOK 264.4mNOK 118.4mNOK 86.7mNOK 37.7mNOK 54.2m
Shares outstanding417m412m395m395m358m334m307m259m234m135m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−NOK 27.8m−NOK 9.8mNOK 2.8m−NOK 45.2m−NOK 61.8m−NOK 61.6m−NOK 31.1m−NOK 28.6m−NOK 25.5m−NOK 67.2m
Capital spending−NOK 20.5m−NOK 4.1m−NOK 8.2m−NOK 17.8m−NOK 37.8m−NOK 54.5m−NOK 28.8m−NOK 9.8m−NOK 13.8m−NOK 42.6m
Free cash flow−NOK 48.3m−NOK 13.9m−NOK 5.4m−NOK 62.9m−NOK 99.5m−NOK 116.1m−NOK 59.9m−NOK 38.5m−NOK 39.3m−NOK 109.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueNOK 65.7mNOK 49.5mNOK 72.2mNOK 54.9mNOK 68.4mNOK 60.9mNOK 65.0mNOK 67.9m
Operating income−NOK 12.9m−NOK 33.6m—−NOK 30.6m−NOK 19.0m−NOK 29.0m−NOK 37.2m−NOK 30.9m
Net income−NOK 23.4m−NOK 36.6m−NOK 48.3m−NOK 28.3m−NOK 25.2m−NOK 33.1m−NOK 41.8m−NOK 35.0m
Diluted earnings per share-0.06-0.09-0.12-0.07-0.06-0.08-0.10-0.08
Cash from operations−NOK 2.0m−NOK 12.0m−NOK 27.0m−NOK 4.0m−NOK 31.0m−NOK 13.0m—−NOK 25.0m
Capital spending−NOK 2.0m−NOK 11.0m−NOK 20.0m−NOK 4.0m−NOK 3.0m−NOK 2.0m−NOK 1.0m—
Free cash flow−NOK 4.0m−NOK 23.0m−NOK 47.0m−NOK 8.0m−NOK 34.0m−NOK 15.0m——
Total assetsNOK 426.6mNOK 369.3mNOK 394.3mNOK 391.3mNOK 387.2mNOK 382.5mNOK 341.4mNOK 365.3m
Cash and short-term investments——NOK 67.0mNOK 65.5mNOK 68.0mNOK 71.9mNOK 22.6mNOK 23.4m
DebtNOK 217.1mNOK 219.4m—NOK 280.2mNOK 277.8mNOK 73.6mNOK 111.6mNOK 89.7m
Shareholders' equity−NOK 30.7m−NOK 110.8m−NOK 74.8m−NOK 27.2mNOK 1.0mNOK 26.9mNOK 62.0mNOK 103.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue28.6%29.9%16.6%
Net income-0.6%5.7%3.0%

Average margins

Over each period

1 year3 years5 years10 years
Net margin-50.3%-60.6%-74.1%-89.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-4.1-5.7-9.7-9.5-19.5-32.0-31.0-7.3-24.9-1.1
Price to sales2.12.75.310.828.247.240.810.23.57.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.